10-QHealthcare

Zoetis Inc.

ZTS · Period ending 2026-09-30 · Filed 2026-11-05 · Updated

In short

Zoetis Inc. (ZTS) has revenue up 2.3% to $9.5B and net income up 7.5% to $2.7B year on year. Its net margin is 28.2%, and it trades at 13.5× trailing earnings. Fisclear flags 1 medium-severity risk and no high-severity ones. How we calculate this

Valuation

Healthcare
Live · Yahoo Finance

Price

$79.11

P/E (TTM)

13.5x

Price ÷ earnings per share

P/B

9.8x

Price ÷ book value

P/S (TTM)

3.4x

Price ÷ revenue per share

Beta

0.68

Moderate market correlation

PEG Ratio

3.7x

P/E ÷ earnings growth rate

52-Week Range

$68.77$79.11 now$132.49

Decision Context

Market appears to be pricing in less growth than this company's historical average, suggesting potential upside if the trajectory continues. Quality and efficiency scores support the business case.

Based on filing period ending Sept 2026

FisclearScore is a quantitative model using public financial data and sector median benchmarks (refreshed monthly). Not financial advice. Always conduct independent due diligence.

ZTS vs

Macro Context

Fed Funds Rate

3.88%

Accommodative

10-Year Treasury

5.13%

2026-10-01

Unemployment

4.2%

Near full employment

CPI Index

336.3

2026-09-01

M2 Money Supply

$23.4T

2026-09-01

The Federal Funds rate stands at 3.88% — a moderately elevated rate environment that raises borrowing costs across the economy; 10-year Treasury yields are at 5.13%, setting the benchmark for long-term corporate borrowing; Unemployment stands at 4.2%; Industrial production index is at 104.0; M2 money supply is $23.4T; CPI index stands at 336.3.

SWOT Analysis — ZTS

Inflationary Boom
Macro lens (Inflationary Boom): Rising costs and tighter margins amplify financial risks in this regime.
✦

Strengths

  • EPS (Diluted): $6.02 (+10.1% YoY) — Earnings per share rose 10% — each share earned more.

  • Total Assets: $15.5B (+8.6% YoY) — Total assets grew 9% — the company's resource base expanded.

  • Net Income: $2.7B (+7.5% YoY) — Profit grew 8% — the company kept more of each dollar earned.

◈

Weaknesses

  • Operating Cash Flow: $2.9B (-1.7% YoY) — Operating cash flow fell 2% but remained positive.

◎

Opportunities

  • Revenue: $9.5B (+2.3% YoY) — Revenue grew 2% — the company sold more goods or services than the prior year.

⚠

Threats

  • Total liabilities represent 78% of total assets — elevated leverage that amplifies both gains and losses.

Year-over-Year Changes

EPS (Diluted)

$6.02

was $5.47

+10.1%

Earnings per share rose 10% — each share earned more.

Total Assets

$15.5B

was $14.2B

+8.6%

Total assets grew 9% — the company's resource base expanded.

Net Income

$2.7B

was $2.5B

+7.5%

Profit grew 8% — the company kept more of each dollar earned.

Revenue

$9.5B

was $9.3B

+2.3%

Revenue grew 2% — the company sold more goods or services than the prior year.

Operating Cash Flow

$2.9B

was $3.0B

−1.7%

Operating cash flow fell 2% but remained positive.

Risk Flags

0 high · 1 medium · 0 low
  • ◈ Medium

    Total liabilities represent 78% of total assets — elevated leverage that amplifies both gains and losses.

Technical Signals

Daily closes · 1-year data

Zoetis Inc.: common questions

Is Zoetis Inc. profitable?

Yes. Zoetis Inc. made a net profit of $2.7B in its latest fiscal year (fiscal 2025), a net margin of 28.2%.

Is Zoetis Inc.'s revenue growing?

Yes. Revenue grew 2.3% year on year, to $9.5B.

What is Zoetis Inc.'s P/E ratio?

Zoetis Inc. trades at 13.5× its trailing twelve-month earnings. In other words, the share price is about 13 times the profit per share the company earned over the past year.

Does Zoetis Inc. pay a dividend?

Yes. Zoetis Inc.'s forward dividend yield is 2.68%, the expected annual dividend as a share of the current share price.

What are the main risks for Zoetis Inc.?

Fisclear's checks flag 1 medium- or high-severity risk. The most serious: Total liabilities represent 78% of total assets — elevated leverage that amplifies both gains and losses.

Answers are generated from the figures in this report (updated 5 Nov 2026). Information, not investment advice.

Latest News

via Finnhub

Filing History — ZTS

Get the weekly digest

5 company reports + macro context every week, free. No spam.

  • Unlimited goal simulations
  • 5 free company report summaries per day
  • Weekly financial insights newsletter

External Links

Trade ZTS

Links open broker research pages. Not an endorsement or recommendation.

Research Zoetis Inc.

Data sourced from SEC EDGAR, FRED (Federal Reserve Economic Data), and Yahoo Finance. For informational purposes only. Not financial advice.